The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest
- PMID: 37804262
- DOI: 10.1016/j.jacep.2023.08.017
The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest
Abstract
Background: There is growing evidence that mitral valve prolapse (MVP) is associated with otherwise unexplained cardiac arrest (UCA). However, reports are hindered by the absence of a systematic ascertainment of alternative diagnoses.
Objectives: This study reports the prevalence and characteristics of MVP in a large cohort of patients with UCA.
Methods: Patients were enrolled following an UCA, defined as cardiac arrest with no coronary artery disease, preserved left ventricular ejection fraction, and no apparent explanation on electrocardiogram. A comprehensive evaluation was performed, and patients were diagnosed with idiopathic ventricular fibrillation (IVF) if no cause was found. Echocardiography reports were reviewed for MVP. Patients with MVP were divided into 2 groups: those with IVF (AMVP) and those with an alternative diagnosis (nonarrhythmic MVP). Patient characteristics were then compared. The long-term outcomes of AMVP were reported.
Results: Among 571 with an initially UCA, 34 patients had MVP (6%). The prevalence of definite MVP was significantly higher in patients with IVF than those with an alternative diagnosis (24 of 366 [6.6%] vs 5 of 205 [2.4%]; P = 0.03). Bileaflet prolapse was significantly associated with AMVP (18 of 23 [78%] vs 1 of 8 [12.5%]; P = 0.001; OR: 25.2). The proportion of patients with AMVP who received appropriate implantable cardioverter-defibrillator therapies over a median follow-up of 42 months was 21.1% (4 of 19).
Conclusions: MVP is associated with otherwise UCA (IVF), with a prevalence of 6.6%. Bileaflet prolapse appears to be a feature of AMVP, although future studies need to ascertain its independent association. A significant proportion of patients with AMVP received appropriate implantable cardioverter-defibrillator therapies during follow-up.
Keywords: arrhythmic mitral valve prolapse; idiopathic ventricular fibrillation; mitral valve prolapse; strength of diagnosis; unexplained cardiac arrest.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures This study was supported by the Heart and Stroke Foundation of Canada (G-13-0002775 and G-14-0005732) and the Canadian Institute of Health Research (Dr Krahn, Principal Investigator, Hearts in Rhythm Organization RN380020–406814). Dr Krahn has received support from the Sauder Family and Heart and Stroke Foundation Chair in Cardiology (Vancouver, British Columbia), the Paul Brunes Chair in Heart Rhythm Disorders (Vancouver, British Columbia), and the Paul Albrechtsen Foundation (Winnipeg, Manitoba). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
The Arrhythmic Mitral Valve Prolapse: Still a Long Way to Go.JACC Clin Electrophysiol. 2023 Dec;9(12):2504-2506. doi: 10.1016/j.jacep.2023.11.004. JACC Clin Electrophysiol. 2023. PMID: 38151301 No abstract available.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous